psa Flashcards

1
Q

Donepezil (anticholinesterase inhb)

A

Bradycardia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Co-beneldopa (bensarazide hydrochloride and levodopa)

A

Hallucinations
Anxiety
(Rare- leucopenia)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Monitoring for Pramipexole

A

BP - risk of postural hypotension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Serious SE of Lamotrigine

A

Stevens Johnson syndrome - rash within 8 weeks of treatment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Risk factor drugs for SJS

A

Anti-epileptics - Carbamazepine
Allopurinol
Sulfonamides
Anti-fungals- Terbinafine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

SE of PPIs

A
  • Low Mg
  • Low Na+
  • Osteoprosis, #risk
  • Microscopic colitis
  • C. diff infections (proliferation of C.diff spores due to reduced gastric acid production)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Digoxin toxicity
Can be precipitated by hypokalaemia (doesn’t compete with potassium for ATP-ase pump), but what other factors?
Why does this happen - related to MOA?
* Symptoms/ adverse effects
* Sign on ECG of digoxin induced changes (not necessarily toxicity)?
* Mx

A
  • Digoxin toxicity triggers: electrolyte imbalance, renal failure, age, drugs (amiodarone and ones causing hypokalaemia eg chlortalidone - thiazide like diuretic)
  • MOI: inhibitsNa+/K+ ATPase pump by competing with potassium so lower levels of potassium increase its effect
  • High potassium reduces its efficacy/risk of treatment failure
  • N&V, confusion, yellow-green vision (xanthopsia), drowsiness, diarrhoea
  • Arrythmias - Bradycardia, AV block
  • ECG: backwards tick - ST segment
  • Mx: Digiband, monitor K+, correct arrythmias
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Most likely SSRI to cause QT prolongation and torsades de pointes

A

Citalopram

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

drugs prolonging QT interval (risk of torsades de pointes - polymorphic VT)

A
  • Methadone
  • Odansetron
  • Digoxin
  • Antipsychotics - Haloperidol/Risperidone
  • SSRIs - Fluoexeteine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Mirtazepine:
Class
MOA
Benefit over other antidepressants

A

NaSSA
Noradrenaline and specific serotinergic antidepressant
Increases levels of NA and serotonin in the brain
Helps with insomina, poor appetite, reduced sexual side effects (libido)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Ticagrelor SE

A

Dyspnoea
Dyspepsia
Dizziness
Diarrhoea
Gout

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Monitoring:
IV Iron Dextran

A

Blood pressure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Monitoring:
Ethambutol

A

(eye-thambutol)
- Visual acuity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Monitoring for beneficial effects:
Furosemide

A

Weight
(overall loss of potassium with furosemide but not most accurate way to assess diuretic effect/volume loss)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Monitoring for beneficial effects:
Factor XA inhibitors (apixaban)

A

patient reports of bruising

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Converting digoxin from IV to oral (via feeding tube)

A

Increase dose by 20-33% due to oral bioavailability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Monitoring requirements for bisphosphonates?
What has to be corrected before starting treatment?

A
  • serum calcium
  • calcium or vitamin d deficiency
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

treatment of PE: considerations for patients with cancer

A

Dalteparin sodium / Tinzaparin
CANCER - find in “Fragmin single dose syringe” –>
- “in patients with solid tumours”
- by weight categories

Also pregnant patients
note these extra considerations in the question stem!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Hypercalcaemia management

A

Aggressive fluid therapy
if hypotensive - fluid challenge
if not hypotensive:
4-6litres of 0.9 % NaCl over 24 hour period
E.g. 500ml over 2 hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

CYP450 Enzymes
Typical substrates

A

Warfarin
OCP
Statins
SSRI
Amitryptiline, codeine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

CYP 450
Inhibitors (risk of toxicity) - SICK FACES

A

Sulfonamides
Isoniazid
Cimetidine
Ketoconazole
Fluconazole
Alchohol, Amiodarone
Cipro
Erythro
Sodium valproate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

CYP 450
Inducers (risk of treatment failure) - CRAP GPS drink grapefruit juice

A

Carbamazepine
Rifampicin
Alcohol (chronic)
Phenytoin
Griseofulvin
Phenobarbitol
St John’s wort, steroids

+ grapefruit juice!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Hydroxychloroquine (DMARD)
main AE

A

(bulls eye) retinopathy
risk of blindness
measure visual acuity/annual screening/need opthal review before

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

interaction between Azathioprine and what cause bone marrow suppression/agranulocytosis?

A

Allopurinol
Xanthine oxidase inhibitor
Reduces breakdown of 6-mercatopurine (active form of axathioprine) -. builds up in DNA of bone marrow cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

drugs causing hypercalcaemia (3)
common non-drug related causes (3)

A
  • Thiazide diuretics (increase renal absorption of Ca)
  • Lithium
  • calcium containing antacids
  • Primary hyperparathyroidism
  • Malignancy - mets, PTHrP from SCLC
  • granulomatous conditions - sarcoid

Other - dehydration, thyrotoxicosis etc

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Drugs causing hypocalcaemia

A
  • PPIs
  • Phenytoin
  • Bisphosphonates (prevent osteoclastic activity)
  • Rifampicin
  • Chemo
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

PALLIATIVE
- Regimens for starting pain treatment in palliative care
- Dose if no comorbidities
- What should be coprescribed?
- Morphine causes which transient side effects (2) and what persistent?
- By what percentage can opioids be increased by?
- Treatments for metastatic bone pain (3)?
- Treatments for nausea and vomiting?

A
  • MR or IR Morphine + IR Breakthrough dose
  • 20-30mg MR/day + 5mg PRN (2-4hrly)
    • stimulant laxatives (senna or bisacodyl)
  • transient - nausea and drowsiness, persistent - laxative
  • Can increase opioids for next dose by 30-50%
  • NSAIDs, Bisphosphonates, radiotherapy (+/- denosumab)
  • Haloperidol, Cyclizine, Levomepromazine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

SIGN Guidelines
* Breakthrough dose
* Choice of opiate in CKD (mild-moderate; severe)

A
  • 1/6 of total daily dose of morphine
  • Oxycodone (mild-mod renal impairment)
  • Alfentanil/Fentanyl/Beprenorphine (severe)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

PALLIATIVE
Opioid conversions
1. Between opioids
* Oral codeine –> oral morphine
* Oral tramadol –> oral morphine
* Oral moprhine –> oral oxycodone
2. From oral to subcut
* Oral morphine –> SC morphine
* Oral morphine –> SC diamorphine
* Oral oxycodone –> SC Diamorphine

  1. From oral to transdermal
    BNF gives conversion factors but approx:
    * 30mg oral morphine =? fentanyl (eg change every 7days)
    * And 24mg oral morphine = ?buprenoprhine (OD, eg change every 3 days)
A
  • Oral codeine/tramadol –> morphine: /10
  • Oral morphine –> oral oxycodone: 1.5/2
  • 30mg oral morphine = 12mcg fentanyl.
  • And 24mg oral morphine = 10mcg buprenorphine
  • Oral morphine –> SC morphine = /2
  • Oral morphine –> SC diamorphine = /3
  • Oral oxycodone –> SC Diamorphine /1.5
  • 30mg oral morphine =12mcg fentanyl (eg change every 7days)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Syringe drivers:
Medications are mixed with what for injection (2 options)?
4 common symptoms:
1. Nausea and vomiting
2. Pain
3. Resp secretions and bowel colic
4. Agitation/restlessness

Which drug are there lots of incompatabilities for - e.g. to metoclopramide, sodium chloride 0.9%, hyoscine butylbromide?

A

Indications
- unsafe swallow
- intestinal obstruction
- dysphagia
- nausea
- weakness, coma
Infusion
- Water (majority)
- 0.9% NaCL e.g. for octreotide/odansetron

Commonly used drugs
1. Nausea and vomitng: Cyclizine, Levomepromazine, Haloperidol, Metoclopramide
2. Secretions: Hyoscine butylbromide, hyoscine hydrobromide, glycopyrronium bromide
3. Agitation: Midazolam, Haloperidol, Levomepromazine
4. PAin: diamorphine

NOTE - CYCLIZINE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Non-pharmacological approach for palliative care
- Pain
- N&V
- Low mood/distress

A
  • TENS machine, physio, CBT
  • regular mouth care, acupressure bands, meal alteration
  • Complementary therapies, CBT, talking therapy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Advantage of using hyoscine butylbromide over hydrobromide for secretions?

A

Butyl- less sedative

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

Amlodipine/dihydropyridines CCBs side effects

A

Ankle swelling
Gum swelling (gingival hyperplasia)
Flushing
Headache

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

Diclofenac - contraindications

A

IHD, PVD, stroke, heart failure

36
Q

Drug monitoring once established on drug:
* Amiodarone - 6 monthly
* Methotrexate: every 3 months
* Azathioprine: every 3 months
* Lithium: every 6 monthg
* Sodium valproate: periodically in 6 months

A

Amiodarone - LFT, TFT (U&E and CXR prior to treatment)
Azathioprine - FBC, LFT
Methotrexate - FBC, LFT, U&E
Lithium - Lithium level, TFT, U7E
Valpriate - LFT

37
Q

Amiodarone (class3 antiarrythmic)
K+ channel inhibitor (and Na+ channel)
SIDE EFFECTS

A
  • Skin/eyes: slate/grey; photosensitivity, corenal deposits
  • Vessels: thrombophlebitis
  • Heart: prolongs QT, bradycardia
  • Fibrosis: lung, liver
    Lunf fibrosis can also cause fever and raised ESR
  • Thyroid dysfunction - hypo/hyper (amiodarone)
  • Neuro: peripheral neuropathy, myopathy

note amiodaraone typically does NOT cause finger clubbing unlike other causes of pulmonary fibrosis

38
Q

Neonaclex

A

Bendoflumethazide

39
Q

Interractions:
Indapamide (diuretic) and colecalciferol (vitamin d)
risk of

A

hypercalcaemia

40
Q

Metclopramide - dopamine antagonist
- rare adverse effect and treatment

A
  • acute dystonias (EPS)
  • seen in first 1-2 days of treatment
  • Procyclidine (antimuscarinic)
41
Q

Phenothiazine - side effect

A

dry mouth
–>primary polydipsia

42
Q

Drug worsening ischemia in peripheral vascular disease

A

Beta blockers - beta adrenergic antagonist - cause peripheral vasoconstriction
e,g, atenolol

43
Q

Drugs contributing to heart failure

A

corticosteroid - prednisolone
calcium channel blocker

44
Q

Insulin
improving glycaemic control in the afternoon
e.g. on biphasic insulin

A

increase morning dose
(if you increased the evening dose it could cause hypoglycaemia in early morning)

45
Q

interactions with simvastatins - higher risk of myopathy and rhabdomyolysis

A

gemfibrozil - a fibrate for hyper choleserolaemia (increases statin concentration); inhibits CYPP2C8
clarithromycin

46
Q

if statin supsected to be cause of myopathy, CK elevated (5x upper limit of normal) or muscular symptoms are severe …

A

discontinue treatment and reintroduce statin at a lower dose if CK levels return to normal (e.g. from 80mg atorvastatin to 40mg PO nightly)
then - switch to other statij with lower risk of myalgia
Simvastatin ->Atorvastatin –> Prav –> Fluva; or a fibrate

47
Q

Drugs causing hyponatreamia

A

Thiazide diuretics
SSRIs
SNRIs
anti-epileptics

48
Q

Dopamine antagonists
Which is safe in Parkinson’s disease?

A

Haloperidol
Metoclopramide
Domperidone - safe in PD as doesn’t cross blood brain barrier

49
Q

Hyperkalaemia
Typical drugs

A
  • K+ sparing diuretics (Spironalactone, Eplerenone)
  • ACE Inhb/ARB (inhibit aldosterone –> less potassium excretion_)
  • Ciclosporin
50
Q

What increases risk of digoxin toxicity?

A

Hypokalaemia
and hypercalcaemia
- because digoxin competes with potassium at the Na+/K+ATPase (removal of potassium increases effect of digoxin on receptor)

51
Q

Aspirin ADRS

A

Haemorrhage
Peptic ulcers
Gastritis
Tinnitus (large doses)

52
Q

Amiodarone ADRs

A

Grey skin
Corneal deposits
Pulmonary fibrosis
Hypo/hyperthyroid

53
Q

Lithium ADRs

A

Early - tremor
Intemediate - fatigue
Late - arrythmias, coma, renal failure, diabetes insipidus

54
Q

Haloperidol
Clozapine

A

EPSE: dyskinesias (acute dystonias, oculogyric crisis)
Agranulocytosis

55
Q

Corticosteroids (Dexamethasone and Prednisolone) ADRs - STEROIDS

A

S: Stomach ulcers
T: Thin skin
E: Edema
R: R/L heart failure
O: Osteoporosis
I : Infection more likely eg candia
D: Diabetes/hyperglycaemia is commonn bt uncommon toprogress ton DM
S: Syndrome (Cushing’s)

56
Q

Fludrocortisone

A

Sodium and water retention (acts like aldosterone)
Hypertension

57
Q

STATIN adrs

A
  • Myalgia
  • Abdominal pain
  • Increased ALT/AST (mild)
  • Rhabdo (midly increased CK throughout or severe)
58
Q

Trimethoprim
(e.g. cotrimoxazole contains trimethoprim)

A

Neutropenia
e.g. two antifolates (trimethoprim and methotrexate) ccan cause bone marrow suppression, pancytopenia and neutropenic sepsis

59
Q

SURGERY RULES
STOP (4)
Diabetics -convert insulin regimens to what?
keep what drugs?
What might need to be supplemented?

A
  1. Hormonal treatments (OCP)
  2. Anticoagulants (heparin, DOAC)
  3. Antiplatelets (aspirin, ticagrelor)
  4. Metformin - stop day before
  5. Lithium - day before

DM - insulin infusion variable rate
Keep
antihypertensives - particularly beta blockers and calcium channel blockers, if BP lower consider stopping a diuretic instead

supplement iv steroids

60
Q

can aspirin be continued in aki

A

yes
is an nsaid but not c/id

61
Q

Lithium toxicity - if dose has not changed, what drugs could be increasing plasma levels?
Management for mild-moderate
and severe

A

Drugs that reduce renal excretion:
ACE-Inhibitors
Diuretics - thiazides
Nsaids
e.g. stop lithium and the offending drugs causing the toxicity
Mx
Mild/moderate; volume resus with normal saline
Severe: haemodialysis

62
Q

Fluid balance charts

A
  • fluid inputs should equal fluid outputs
  • if hypernatremic 5% glucose solution is a better choice
  • potassium can be corrected with KCl (40mmol/day) and can never exceed 20mmol/hour
  • eg if fluid negative - work out at what rate the patient is losing fluids and prescribe fluids at a rate that matches this
  • eg loss of 6 litres / 24 hours = 1 litre every 4 hours so replace with fluids over 4 hours
63
Q

maintenance fluids
adults req
ederly req
assuming the blood results are normal the maintenance fluids should include (3) in 24hrs

A

generally = 3 L per day (in 8hrly bags)
elderly = 2L (12hrly bags)
regime
2 salty, 1 sweet
2L 0.9% NaCl
1L 5% glucose

64
Q

1st line antidiabetic in ckd

A

gliclazide

65
Q

who requires an ecg for olanzapine

A

if cardiovascular risk factors
eg long term smoker

66
Q

steroid conversion charts

A

search “glucocorticoid therapy”
remember doubek dose during infection/sepsis

67
Q

Laxatives - when to use/avoid
Bulk-forming (isphagula husk)
Stimulant (senna, bisacodyl)
Stimulant and faecal softener (docusate sodium)
Faecal softeners (arachis oil enemea, docusate sodium enema)
Osmotic laxative (lactulose, macrogol 3350)

A
  • bulk forming: short term constipation; avoid in obstruction, colitis and cframps, takes 72 hours to have affect, avoid in opioid-induced consipation
  • stimulant: stools soft but difficult to pass, second line for short-duration constipation
  • faecal softener: can be used in constipation in palliative care
  • osmotic laxative: causes bloating, first line hepatic encephalopathy, use in constipation in palliative care
68
Q

marker of improvement:
aminophylline
antibiotic treatment for pneumonia

A

o2 sats
RR, ABG, O2 sats

69
Q

pre-dose (trough) concentrations for vancomycin

A

1-15mg/l

70
Q

Cause of dyspepsia

A

Steroids- prednisolone
Alendronic acid -
Ibuprofen

71
Q

Cause of peripheral oedema (ankle swelling)

A

Amlodipine / CCBs
Naproxen

72
Q

management for haloperidol-associated parkinsonism (Drug induced epse)

A

procyclidine hydrochloride (anticholinergic)

73
Q

Constipation - treatment options
Bulking agents (isphagula husk)
Stimulant (senna, bisacodyl)
Osmotics (lactulose, phosphate enema, polytethylene glycol “Movicol”)
Stool softener (docusate sodium - also a stimulant at higher doses; arachis oil)

A
  • Bulking agents- contraindicated in fecal impaction/reduced gut motility; can take 72 hours to take effect
  • Stimulants: CId in acute abdomen, may make abdominal cramps worse
  • Osmotics: CId in IBD (enema), may cause bloating
  • Stool softener: good for faecal impaction/ reduced gut motility
74
Q

Constipation first line for children
(no fecal impaction)

A

Osmotic laxatives:
Search “Movicol -
polyethylene glycol 3350 plus electrolytes
1 sachet oral once daily 28 days
or Lactulose - liquid firm
second line is senna

75
Q

Asthma adults

A
  1. Salbutamol
  2. Fluticasone
  3. Montelukast
76
Q

AKI - drugs to stop

A

DAMN - PCL
also codeine (reduced excretion in AKI so more likely to have AEs)

77
Q

Risks of ACE/I/ARBs in Afro-Carribean

A

higher risk angioedema
can happen in CCBs - but less common

78
Q

Drugs causing urinary retention

A

Opiods
TCA - Imipramine
anticholinergics
general anaesthetics
alpha agonists
diazepam
nsaids
ccbs
antihistamines
alcohol

79
Q

drugs causing weight gain

A

antidiabeitcs - pioglitazones, gliclazides
mirtazepine
depot provera injection

80
Q

drugs causing cold peripheries

A

beta blockers
methylphenidate

81
Q

diabetes treatment targets
- diet and lifestyle alone / metformin or one antidiabetic alone
- on a drug associated with hypoglycaemia

if blood sugars aren’t controlled on one and rise to above 58 –> drug treatment should be intesified or add a second
- on two antidiabetics

A

Hba1c <48mmol
<53 mmol
<53 mmol

82
Q

Drugs to stop before surgery

A

ILACKOP
Insulin - INSTEAD variable rate insulin with long acting, omit short acting
Lithiuim
Anticoagulatns/antiplatelets (except aspirin, generally)
COCP/HRT
K+ sparing diuretics
Oral hypoglycaemics - EG nbm
Perindopril/ACE-Inhbs

83
Q

Fluids
Adults
Elderly
Electrolytes - sweet/salty
Potassium

A

Adults: 3L per day (3 x 8hrly bags)
Elderly: 2l (2 x12 hr bags)
Electrolytes: 1 salty, 2 sweet
K+ = 1mmol/kg/day

84
Q

Anti-emetics
- general
-nausea but cardiac failure/risk of cardiac failure

A

Cyclizine 50mg 8hrly
Metoclopramide 10mg 8hrly - avoid in parkison’s disease and young women due to dyskenesia risk
Post-op vomiting - Odansetron

85
Q

never prescribe beta blockers with verapamil due to

A

life threatening bradycardias